Abstract
A plenitude of reasons, including tumour heterogeneity, mechanisms of resistance to therapy, a complex pathogenesis, in which cancer stem cells are involved, contribute to the poor outcome of HNSCC patients after therapy. The roles of vital signalling proteins are constantly unravelled, and different types of inhibitors are examined yielding novel potential targeting strategies. However, there will be a long way to go, before drugs targeting these molecules will be available in routine clinical practice. In this review the focus will be on these novel targets, as well as inhibiting agents, which nowadays are combined to an increasing degree. Additionally, the role proteomics plays in modern drug research will be highlighted.
Keywords: Cancer stem cells, epithelial-to-mesenchymal transition, HNSCC, proteomics, targeted therapy.
Current Proteomics
Title:Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials
Volume: 10 Issue: 2
Author(s): Eva-Maria Schottdorf
Affiliation:
Keywords: Cancer stem cells, epithelial-to-mesenchymal transition, HNSCC, proteomics, targeted therapy.
Abstract: A plenitude of reasons, including tumour heterogeneity, mechanisms of resistance to therapy, a complex pathogenesis, in which cancer stem cells are involved, contribute to the poor outcome of HNSCC patients after therapy. The roles of vital signalling proteins are constantly unravelled, and different types of inhibitors are examined yielding novel potential targeting strategies. However, there will be a long way to go, before drugs targeting these molecules will be available in routine clinical practice. In this review the focus will be on these novel targets, as well as inhibiting agents, which nowadays are combined to an increasing degree. Additionally, the role proteomics plays in modern drug research will be highlighted.
Export Options
About this article
Cite this article as:
Schottdorf Eva-Maria, Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials, Current Proteomics 2013; 10 (2) . https://dx.doi.org/10.2174/1570164611310020007
DOI https://dx.doi.org/10.2174/1570164611310020007 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analytical Methods for Metallothionein Detection
Current Analytical Chemistry Editorial (Hot Topic: miRNA in the Pathogenesis and Therapy for Gastrointestinal and Hepatic Cancers)
Current Pharmaceutical Design Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells
Current Pharmaceutical Design MET and ALK as Targets for the Treatment of NSCLC
Current Pharmaceutical Design Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro
Anti-Cancer Agents in Medicinal Chemistry Medical Expert Systems
Current Bioinformatics Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Cosmeceutical Aptitudes of Azelaic Acid
Current Drug Research Reviews Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms
Current Drug Metabolism Overview of Systems Biology and Omics Technologies
Current Medicinal Chemistry Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy
Current Drug Targets Subject Index to Volume 5
Current Genomics Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Current Cancer Drug Targets Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters Recent Developments in Taxane Drug Delivery
Current Drug Delivery Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Lymphatics and Inflammation
Current Medicinal Chemistry Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition